Enregistrement :
13
de
30
(2017-02-06
à
2017-09-01)
Politique ou Programme
Common Drug Review, importance of meaningful public/patient input into the drug review process
Encouraging the development of a rare disease strategy in Canada (similar to the policies for rare diseases in Europe and the United States).
Politique ou Programme, Règlement
Health Canada with respect to the regulation of pancreatic enzymes used in the management of cystic fibrosis. Recommend product should be listed on Schedule F to the Food and Drugs Regulations.
Politique ou Programme, Subvention, Contribution ou autre avantage financier
Increased federal investment in health-related research. We worked with the Health Charities Coalition of Canada (HCCC) to draft content for a press release urging the federal government to invest more in basic science in Canada.